RSS Amplifier

Blog

The Active Surveillor

Saving Prostates Daily

howardwolinsky.substack.comSource feed ↗10 posts

Live Last read · last published · next check

Written by

Latest posts

Screening Gap: Men With Disabilities Miss Out on PSA Testing

New bureaucratic PCa mess in UK

Paid subscribers sign up to hear Dr. Scott Eggener as first speaker in blockbuster AS27 webinar set for January 14

He's giving an update on surveillance and the cancer label

When an AS patient faces treatment decisions: Can Transdermal Estradiol Provide an Effective Androgen Deprivation Option for Active Surveillance Patients Facing a Change to Active Therapy?

By Howard Wolinsky, Editor, The Active Surveillor

When Irish Prostates Are Smiling (Sure It's Like A Morn In Spring)--'Smarter Prostate Cancer Screening'

New screening pilots and gentler surveillance aim to catch more cancers while treating fewer men unnecessarily as Ireland fine-tunes a DIY approach. In The Lilt Of Irish Laughter You Can Hear The Ang

The VA’s Quiet Revolution: Active Surveillance Reaches Near‑European Heights

By Howard Wolinsky, Editor, The Active Surveillor

Cluster of BBC Prostate‑Cancer Disclosures, and the UK Fight Over PSA Testing

By Howard Wolinsky, Editor, The Active Surveillor Edward Stourton spent more than four decades as one of the BBC’s most reliable narrators of British public life — calm in crises, sharp in interviews, and unmistakably authoritative behind the microphone. His death on July 20 at age 68, after nearly a decade living with prostate cancer, landed with unusual force. It wasn’t just the loss of a…

Taming the Glucose Monster — Again

By Howard Wolinsky, Editor, The Active Surveillor

Hunter’s Emotional BBC Interview, Jill’s Seven‑Times‑a‑Night Alarm Mark New Transparency on Biden’s Cancer

By Howard Wolinsky, Editor, The Active Surveillor

Australia Guidelines Turn World on Prostate Care: PSA at 45, MRI‑First, DRE Gone — and Testing Continues After 70 plus BRCA testing and more

Firstnew guidelines in 10 years

Why the Gut Microbiome is on Prostate Cancer Researchers’ Radar

By Howard Wolinsky, Editor, The Active Surveillor